XML 44 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
OPERATING SEGMENTS
 12 Months Ended
Dec. 31, 2017
Disclosure of operating segments [abstract]  
OPERATING SEGMENTS
NOTE 21: -
OPERATING SEGMENTS

a.
General:

Commencing January 1, 2012, the Company operates in three segments. The segments were determined on the basis of information considered by the Chief Operating Decision-Maker ("CODM") for purposes of decision-making on the allocation of resources and evaluation of performance. The following Company's segments are engaged in business activities for which they earn revenues and incur expenses, their results are reviewed by the CODM and discrete financial information is available:

Evogene segment
-
Develops seed traits, ag-chemical products, and ag-biological products to improve plant performance.
     
Evofuel segment
-
Develops improved castor bean seeds to serve as a feedstock source for biofuel and other industrial uses.
     
Biomica
  -
Discovery and development of human microbiome-based therapeutics

Segments performance is determined based on operating loss reported in the financial statements. The results of a segment reported to the CODM include items attributed directly to a segment, as well as other items, which are indirectly attributed using reasonable assumptions.

b.
The following table presents our revenues and operating loss by segments:
 
   
Evogene
    
Evofuel
    
Biomica
    
Adjustments
    
Total
  
                               
For the Year Ended December 31, 2017
                              
                               
Revenues
  
$
3,247
    
$
134
    
$
-
    
$
-
    
$
3,381
  
                                         
Operating loss
  
$
(21,430
)
  
$
(313
)
  
$
(204
)
  
$
-
    
$
(21,947
)
                                         
Net financing income
                                  
$
1,120
  
                                         
Loss before taxes on income
                                  
$
(20,827
)

 
   
Evogene
    
Evofuel
    
Adjustments
    
Total
  
                         
For the Year Ended December 31, 2016
                        
                         
Revenues
  
$
6,540
    
$
-
    
$
-
    
$
6,540
  
                                 
Operating loss
  
$
(20,168
)
  
$
(921
)
  
$
-
    
$
(21,089
)
                                 
Net financing income
                            
1,533
  
                                 
Loss before taxes on income
                          
$
(19,556
)
 
   
Evogene
    
Evofuel
    
Adjustments
    
Total
  
                         
For the Year Ended December 31, 2015
                        
                         
Revenues
  
$
11,129
    
$
-
    
$
-
    
$
11,129
  
                                 
Operating loss
  
$
(16,146
)
  
$
(1,775
)
  
$
-
    
$
(17,921
)
                                 
Net financing income
                            
708
  
                                 
Loss before taxes on income
                          
$
(17,213
)

c.
Major customers:

Revenues from major customers each of whom amounts to 10% or more, of total revenues:

   
Year ended December 31,
  
   
2017
    
2016
    
2015
  
                   
Customer A (shareholder)
    
66
%
    
77
%
    
77
%
Customer B
    
10
%
    
12
%
    
-
  
Customer C
    
*) -
 
    
11
%
    
14
%
 
*) Represents an amount lower than 10%.
 
See also Note 22 (a).

d.
Geographical information:

Revenues based on the location of the customers, are as follows:

   
Year ended December 31,
  
   
2017
    
2016
    
2015
  
                   
United States
    
76
%
    
89
%
    
86
%
Germany
    
10
%
    
11
%
    
14
%
Other
    
14
%
    
-
      
-
  
                         
     
100
%
    
100
%
    
100
%